Axsome Therapeutics Inc (AXSM)
76.54
-0.82
(-1.05%)
USD |
NASDAQ |
May 17, 16:00
76.54
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Free Cash Flow: -193.34M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -193.34M |
| December 31, 2023 | -145.66M |
| September 30, 2023 | -143.04M |
| June 30, 2023 | -111.94M |
| March 31, 2023 | -90.24M |
| December 31, 2022 | -117.21M |
| September 30, 2022 | -118.31M |
| June 30, 2022 | -122.52M |
| March 31, 2022 | -114.16M |
| December 31, 2021 | -108.53M |
| September 30, 2021 | -100.27M |
| June 30, 2021 | -88.98M |
| March 31, 2021 | -82.47M |
| December 31, 2020 | -78.50M |
| September 30, 2020 | -75.50M |
| June 30, 2020 | -70.38M |
| March 31, 2020 | -60.17M |
| Date | Value |
|---|---|
| December 31, 2019 | -46.39M |
| September 30, 2019 | -38.62M |
| June 30, 2019 | -33.91M |
| March 31, 2019 | -32.89M |
| December 31, 2018 | -30.09M |
| September 30, 2018 | -26.58M |
| June 30, 2018 | -27.11M |
| March 31, 2018 | -26.54M |
| December 31, 2017 | -26.48M |
| September 30, 2017 | -27.41M |
| June 30, 2017 | -25.84M |
| March 31, 2017 | -24.07M |
| December 31, 2016 | -21.39M |
| September 30, 2016 | -16.42M |
| June 30, 2016 | -13.47M |
| March 31, 2016 | -10.25M |
| December 31, 2015 | -7.459M |
Free Cash Flow Range, Past 5 Years
-193.34M
Minimum
Mar 2024
-33.91M
Maximum
Jun 2019
-97.01M
Average
-95.25M
Median
Free Cash Flow Benchmarks
| Krystal Biotech Inc | -54.44M |
| Catalyst Pharmaceuticals Inc | 81.59M |
| Vertex Pharmaceuticals Inc | 3.479B |
| Vistagen Therapeutics Inc | -26.12M |
| ADMA Biologics Inc | 15.91M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -53.47M |
| Cash from Investing (Quarterly) | -0.098M |
| Cash from Financing (Quarterly) | -1.187M |
| Free Cash Flow Per Share (Quarterly) | -1.130 |
| Free Cash Flow to Equity (Quarterly) | -54.18M |
| Free Cash Flow to Firm (Quarterly) | -52.48M |
| Free Cash Flow Yield | -5.45% |